Ford has a 24 billion market cap on negative 3 billion revenue. Ford doesn't have market exclusivity or the margins pharma has. Pharma's run negative when they have indications with too few patients. There is not a lack of patients for COVID-19, HIV, cancer and so many more.

I don't expect much more than $15 on COVID-19 alone. But the rest of the year still has numerous catalysts to drive the price up further.